TAK-555-5002: Observational Study to Assess Maternal and Fetal Outcomes Following Exposure to Prucalopride during Pregnancy

First published 15/07/2021

Last updated 04/12/2025

EU PAS number:

EUPAS41866

Study

Ongoing

Download as PDF

Documents

Study protocol

Initial protocol

TAK-555-5002 Protocol V3.0_redacted.pdf

English (553.73 KB - PDF) View document

Study results

No information provided.

Study report

No information provided.

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

No information provided.

TAK-555-5002: Observational Study to Assess Maternal and Fetal Outcomes Following Exposure to Prucalopride during Pregnancy

Secondary tabs

Share this page